ViiV Releases Promising Phase 2 Data on Potential Long-acting HIV Drugs

Seeking Alpha17minutes ago

Gilead Sciences Presented First Clinical Data For Its Investigational Once-Yearly Lenacapavir For HIV Prevention At CROI 2025 And Published In The Lancet

Benzinga13:37 ET

10 Health Care Stocks Whale Activity In Today's Session

Benzinga13:35 ET

YPF Says Chevron, Shell to Join Vaca Muerta Sur Project in Argentina

Seeking Alpha13:15 ET

Arvinas, Pfizer Breast Cancer Drug Fails To Show Progression-Free Survival Benefit In Trial

Benzinga12:30 ET

10 Defensive Dividend Energy Stocks as Wall Street Struggles in 2025

Seeking AlphaMar 11 10:29 ET